Celldex Therapeutics, Inc. - Company & Market Research Reports

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.


Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Global HIV Therapeutic & Preventive Vaccines Market - Segmented by Type and Geography 2017 - 2022 - Product Thumbnail Image

Global HIV Therapeutic & Preventive Vaccines Market - Segmented by Type and Geography 2017 - 2022

  • Report
  • 205 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • Report
  • 1005 Pages
From
Global Cancer Vaccine Market & Clinical Trial Insight - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trial Insight

  • Clinical Trials
  • 750 Pages
From
Global Monoclonal Antibodies Market - by Type, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023) - Product Thumbnail Image

Global Monoclonal Antibodies Market - by Type, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)

  • Report
  • 122 Pages
From
Brain Hemorrhage - Pipeline Insight, 2018 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Global HIV Vaccine Market & Clinical Trial Outlook 2022 - Product Thumbnail Image

Global HIV Vaccine Market & Clinical Trial Outlook 2022

  • Report
  • 200 Pages
From
Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021 - Product Thumbnail Image

Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021

  • Report
  • 148 Pages
From
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany - Product Thumbnail Image

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • Report
  • 122 Pages
From
Neurofibromatosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Neurofibromatosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 128 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022 - Product Thumbnail Image

Global Antibody Drug Conjugates Market By Drug (ADCETRIS, Kadcyla), Pipeline Analysis (By Phase, Mode of Action, Linker, Technology, and Indication) Outlook 2022

  • Report
  • 120 Pages
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Report
  • 886 Pages
From
Global Cancer Monoclonal Antibodies Market 2017-2021 - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market 2017-2021

  • Report
  • 115 Pages
From
Neurofibromatosis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Neurofibromatosis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 91 Pages
From
HIV / AIDS - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2015

  • Report
  • 916 Pages
From
Loading Indicator
adroll